These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35335991)

  • 21. Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism.
    Wang L; Wang A; Zhao X; Liu X; Wang D; Sun F; Li Y
    Int J Pharm; 2012 May; 427(2):284-92. PubMed ID: 22387369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro, ex-vivo, and in-vivo evaluation of buprenorphine HCl release from an in situ forming gel of PLGA-PEG-PLGA using N‑methyl‑2‑pyrrolidone as solvent.
    Kamali H; Khodaverdi E; Hadizadeh F; Mohajeri SA
    Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():561-575. PubMed ID: 30606566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fabrication of PLGA
    Yang S; Hu M; Liu W; Hou N; Yin K; Shen C; Shang Q
    J Biomater Sci Polym Ed; 2021 Jun; 32(8):994-1008. PubMed ID: 33583329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive characterization of in situ forming implant diffusivity using diffusion-weighted MRI.
    Hopkins KA; Vike N; Li X; Kennedy J; Simmons E; Rispoli J; Solorio L
    J Control Release; 2019 Sep; 309():289-301. PubMed ID: 31323243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Biodegradable Injectable In situ Forming Implants for Sustained Release of Lornoxicam.
    Christian R; Thakkar V; Patel T; Gohel M; Baldaniya L; Shah P; Pandya T; Gandhi T
    Curr Drug Deliv; 2019; 16(1):66-78. PubMed ID: 30264681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical effect of ultrasound-guided injection of biodegradable poly(lactic-co-glycolic acid)-Fe
    Liang B; Zuo GQ; Zheng YY; He S; Zuo DY
    Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):911-915. PubMed ID: 28073412
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of implant formation on drug release kinetics of in situ forming implants.
    Suh MS; Kastellorizios M; Tipnis N; Zou Y; Wang Y; Choi S; Burgess DJ
    Int J Pharm; 2021 Jan; 592():120105. PubMed ID: 33232755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In situ forming PLA and PLGA implants for the parenteral administration of Cannabidiol.
    Lozza I; Martín-Sabroso C; Torres-Suárez AI; Fraguas-Sánchez AI
    Int J Pharm; 2024 Jul; 661():124468. PubMed ID: 39013533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel injectable in situ forming poly-DL-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug delivery.
    Yehia SA; Elshafeey AH; Elsayed I
    J Liposome Res; 2012 Jun; 22(2):128-38. PubMed ID: 22091557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model.
    Solorio L; Wu H; Hernandez C; Gangolli M; Exner AA
    Ther Deliv; 2016; 7(4):201-12. PubMed ID: 27010983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Characterization of Novel In-Situ-Forming Oleogels.
    Dümichen A; Lucas H; Trutschel ML; Mäder K
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimodal imaging approach to examine biodistribution kinetics of Cabotegravir (GSK1265744) long acting parenteral formulation in rat.
    Jucker BM; Alsaid H; Rambo M; Lenhard SC; Hoang B; Xie F; Groseclose MR; Castellino S; Damian V; Bowers G; Gupta M
    J Control Release; 2017 Dec; 268():102-112. PubMed ID: 29042321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior.
    Astaneh R; Erfan M; Moghimi H; Mobedi H
    J Pharm Sci; 2009 Jan; 98(1):135-45. PubMed ID: 18493999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of dolutegravir 100 mg once daily with rifampicin.
    Wang X; Cerrone M; Ferretti F; Castrillo N; Maartens G; McClure M; Boffito M
    Int J Antimicrob Agents; 2019 Aug; 54(2):202-206. PubMed ID: 31002950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems.
    Patel RB; Carlson AN; Solorio L; Exner AA
    J Biomed Mater Res A; 2010 Aug; 94(2):476-84. PubMed ID: 20186771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
    Bisht R; Jaiswal JK; Rupenthal ID
    Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation.
    Song I; Weller S; Patel J; Borland J; Wynne B; Choukour M; Jerva F; Piscitelli S
    Eur J Clin Pharmacol; 2016 Jun; 72(6):665-70. PubMed ID: 26898568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of the Antitumor Efficacy of Intratumoral Administration of Cucurbitacin Poly(Lactic-co-Glycolic Acid) Microspheres Incorporated in In Situ-Forming Sucrose Acetate Isobutyrate Depots.
    Wang JW; Xu JH; Li J; Zhao MH; Zhang HF; Liu DC; Zhou X; Xu H
    J Pharm Sci; 2016 Jan; 105(1):205-11. PubMed ID: 26566075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultra-long acting prodrug of dolutegravir and delivery system - Physicochemical, pharmacokinetic and formulation characterizations.
    Khuroo T; Dharani S; Mohamed EM; Immadi S; Wu Z; Khan MA; Lu D; Nehete P; Rahman Z
    Int J Pharm; 2021 Sep; 607():120889. PubMed ID: 34271151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.